Literature DB >> 14747268

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy.

Eric S Albright, Renee Desmond, David S H Bell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747268     DOI: 10.2337/diacare.27.2.632

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  21 in total

Review 1.  Insulin analogues in type 1 diabetes mellitus: getting better all the time.

Authors:  Chantal Mathieu; Pieter Gillard; Katrien Benhalima
Journal:  Nat Rev Endocrinol       Date:  2017-04-21       Impact factor: 43.330

2.  A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec.

Authors:  Stefan Korsatko; Sigrid Deller; Gerd Koehler; Julia K Mader; Katharina Neubauer; Charlotte L Adrian; Henrik Thomsen; Hanne Haahr; Thomas R Pieber
Journal:  Clin Drug Investig       Date:  2013-07       Impact factor: 2.859

Review 3.  Clinical experience with insulin glargine in type 1 diabetes.

Authors:  Satish Garg; Emily Moser; Marie-Paule Dain; Anastasia Rodionova
Journal:  Diabetes Technol Ther       Date:  2010-10-22       Impact factor: 6.118

4.  Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic? Diabetologia 49:2793-2794.

Authors:  D S H Bell
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

Review 5.  Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.

Authors:  Therese M Chapman; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus.

Authors:  Anna Kabakov; Andrew Merker
Journal:  J Pharm Technol       Date:  2021-11-10

Review 7.  New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations.

Authors:  Paris Roach
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 8.  Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?

Authors:  David S H Bell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Detemir as a once-daily basal insulin in type 2 diabetes.

Authors:  Scott E Nelson
Journal:  Clin Pharmacol       Date:  2011-08-18

10.  Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Authors:  Peter Sharplin; Jason Gordon; John R Peters; Anthony P Tetlow; Andrea J Longman; Philip McEwan
Journal:  Cardiovasc Diabetol       Date:  2009-02-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.